• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

142.54 -0.70 (-0.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,770,155
Open 141.46
Bid (Size) 139.12 (100)
Ask (Size) 142.50 (100)
Prev. Close 143.24
Today's Range 138.23 - 143.86
52wk Range 78.55 - 155.53
Shares Outstanding 152,800,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Surging Stock on Our Buy List and 2 Facing Challenges
May 14, 2026
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
News headline image
PacBio (PACB) Q1 2026 Earnings Call Transcript ↗
May 08, 2026
PacBio (PACB) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
+6.1%
+6.1%
1 Month
+7.4%
+7.4%
3 Month
+22.3%
+22.3%
6 Month
+18.7%
+18.7%
1 Year
+70.5%
+70.5%

More News

Read More
News headline image
5 Revealing Analyst Questions From Illumina’s Q1 Earnings Call
May 07, 2026
Via StockStory
Topics Earnings
Illumina Q1 2026 Earnings Beat Overshadowed by Revenue Miss, ILMN Slides ↗
April 30, 2026
Via Chartmill
Topics Earnings
News headline image
3 Profitable Stocks We’re Skeptical Of
May 06, 2026
Via StockStory
News headline image
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
May 05, 2026
Via StockStory
News headline image
PacBio (PACB) Q1 Earnings Report Preview: What To Look For
May 05, 2026
Via StockStory
News headline image
Uber, Exxon Mobil, Illumina, Diamondback Energy: CNBC's 'Final Trades' ↗
May 05, 2026
Via Benzinga
News headline image
ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges
May 01, 2026
Via StockStory
News headline image
Illumina (ILMN) Q1 2026 Earnings Transcript ↗
April 30, 2026
Via The Motley Fool
News headline image
Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026
April 30, 2026
Via StockStory
News headline image
Illumina (ILMN) Q1 Earnings Report Preview: What To Look For
April 28, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades' ↗
April 20, 2026
Via Benzinga
News headline image
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
April 15, 2026
Via MarketMinute
Topics Economy
News headline image
3 Unpopular Stocks That Concern Us
April 13, 2026
Via StockStory
News headline image
3 Reasons to Avoid ILMN and 1 Stock to Buy Instead
April 09, 2026
Via StockStory
Topics Stocks
News headline image
1 Mid-Cap Stock for Long-Term Investors and 2 We Brush Off
March 31, 2026
Via StockStory
News headline image
Nasdaq Overhauls Index Rules to Capture Mega-Cap IPOs: The Era of 'Fast Entry' and Phantom Market Caps Begins
March 30, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
March 27, 2026
Via StockStory
Topics Economy Government Stocks
News headline image
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop ↗
March 23, 2026
Via The Motley Fool
News headline image
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
March 23, 2026
Via MarketMinute
Topics Supply Chain
News headline image
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders
March 17, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
ADS and Gamma Scientific Release Joint White Paper on Practical Path to NHTSA ADB Compliance
March 17, 2026
Via PRLog
News headline image
Illumina Stock Sees RS Rating Jump To 82 ↗
March 16, 2026
Via Investor's Business Daily
News headline image
3 Profitable Stocks with Open Questions
March 09, 2026
Via StockStory

Frequently Asked Questions

Is Illumina, Inc. - Common Stock publicly traded?
Yes, Illumina, Inc. - Common Stock is publicly traded.
What exchange does Illumina, Inc. - Common Stock trade on?
Illumina, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Illumina, Inc. - Common Stock?
The ticker symbol for Illumina, Inc. - Common Stock is ILMN on the Nasdaq Stock Market
What is the current price of Illumina, Inc. - Common Stock?
The current price of Illumina, Inc. - Common Stock is 142.54
When was Illumina, Inc. - Common Stock last traded?
The last trade of Illumina, Inc. - Common Stock was at 05/15/26 04:00 PM ET
What is the market capitalization of Illumina, Inc. - Common Stock?
The market capitalization of Illumina, Inc. - Common Stock is 21.78B
How many shares of Illumina, Inc. - Common Stock are outstanding?
Illumina, Inc. - Common Stock has 22B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap